CompletedNot Applicable

Role of Pre-operative CPET in Pancreatoduodenectomy

United Kingdom113 participantsStarted 2021-03-24

Plain-language summary

A clinical database has been prospectively maintained by the investigators, with details of pancreatic resections since January 2016. It includes pre-operative details, details of multidisciplinary team (MDT) meeting, details of pre-operative biliary stenting, intra-operative details, post-operative morbidity and mortality, details of histopathological diagnosis, recurrence and survival. Data was collected onto the database (excel sheet) from trust data software, clinic letters, Somerset Cancer registry and clinical portal.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All pancreatic resections during the study period, performed for: * Cholangiocarcinoma * Duodenal and periampullary tumors * Pancreatic tumors * All the patients in the database who have undergone Whipple (pancreatoduodenectomy) Exclusion Criteria: * Duodenal or gastric resections, not in conjunction with pancreatic resections * Distal pancreatectomy * Partial excision * Enucleation of lesions * Open and close when inoperable

What they're measuring

Cardiopulmonary Exercise Testing (CPET)/ Portsmouth - Physiological and Operative Severity Score for the enumeration of Mortality and morbidity (P-POSSUM) predicted mortality versus actual 30 day mortality

Timeframe: 30 days

Trial details

NCT IDNCT06068452

SponsorEast Lancashire Hospitals NHS Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-15

View on ClinicalTrials.gov More Pancreas Cancer trials